Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 824 of 6351
-
Can a personalized exercise plan boost heart rehab for seniors?
Disease control OngoingThe goal of this clinical trial is to compare two types of exercise prescriptions in cardiac rehabilitation eligible older adults (60 years or older) with heart disease. The investigators found in a single site pilot trial (insert NCTxxx) that one exercise prescription was better…
Sponsor: Baystate Medical Center • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
New drug combo shows promise against rare brain cancer
Disease control CompletedThis study was a single-centre, retrospective study that retrospectively collected first-line PCNSL patients receiving methotrexate-based chemotherapy ± orelabrutinib at Huashan Hospital of Fudan University. The study was divided into two retrospective cohorts, Cohort A was a coh…
Sponsor: Huashan Hospital • Aim: Disease control
Last updated Jun 26, 2026 17:57 UTC
-
New drug cocktail targets childhood cancers with missing proteins
Disease control OngoingThis research study involves a combination of three drugs given together as a possible treatment for malignant rhabdoid tumor, atypical teratoid rhabdoid tumor, epithelioid sarcoma, chordoma or other tumors that are deficient in one of two possible proteins, either INI-1 (SMARCB1…
Phase 1/2 • Sponsor: Susan Chi, MD • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New strategies boost HIV prevention pills for black women in the south
Prevention CompletedBlack women experience one of the highest incidences of HIV among all subpopulations in the United States, but pre-exposure prophylaxis (PrEP) use among Black cisgender women is very limited. The investigators will implement four strategies (provider training, patient education, …
Sponsor: University of Chicago • Aim: Prevention
Last updated Jun 27, 2026 12:37 UTC
-
New drug cocktail shows promise for tough blood cancer
Disease control Recruiting nowThis phase I/II trial tests the safety and effectiveness of glofitamab (with obinutuzumab pretreatment), venetoclax, and lenalidomide in treating patients with newly diagnosed, high risk mantle cell lymphoma. Glofitamab and obinutuzumab are monoclonal antibodies that may interfer…
Phase 1/2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New COVID-19 vaccine boosters target latest variants in large trial
Vaccine CompletedThe purpose of this clinical protocol is to learn about the safety, tolerability, and immunogenicity of new BNT162b2 RNA-based vaccine candidates targeting new variants of SARS-CoV-2 in healthy people. Substudy A: * This study will evaluate the safety, tolerability, and immunog…
Phase 2/3 • Sponsor: BioNTech SE • Aim: Vaccine
Last updated Jun 27, 2026 12:24 UTC
-
Food delivery plus counseling may help rural smokers kick the habit
Disease control OngoingThe long-term goal of FRESH Delivers is to fill a critical gap in knowledge on the role of a home-based food delivery social intervention in the elimination of tobacco-caused cancer health burdens. The central hypothesis is that smokers who receive real-time video-based motivatio…
Sponsor: University of Arkansas • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Could an old malaria drug boost cancer treatment?
Disease control OngoingThis is a two arm, 2-center, Phase II, study of 5-FU, irinotecan, bevacizumab (FOLFIRI-beva) and hydroxychloroquine (HCQ) in patients with previously untreated metastatic colorectal cancer (mCRC). Up to 155 patients will be screened for DTP-signature and up to 31 evaluable patie…
Phase 2 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
AI reads MRI scans to spot hidden sarcomas
Diagnosis CompletedThis research aims to improve the way of deciding whether a lump in soft tissue such as fat or muscle is a type of cancer called a soft tissue sarcoma, or if it is benign (non-cancerous). To do this the investigators will use routine clinical MRI scans, additional quantitative MR…
Sponsor: The Leeds Teaching Hospitals NHS Trust • Aim: Diagnosis
Last updated Jun 27, 2026 12:08 UTC
-
Blood test may spot hidden pancreatic cancer after surgery
Knowledge-focused OngoingShort-term relapse and poor survival are prevalent in patients with pancreatic adenocarcinoma (PAAD) after surgeries. Despite the importance of adjuvant treatments for resected PAAD patients, there is currently no suitable biomarker to identify those individuals with high risk of…
Sponsor: BAIYONG SHEN • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
New drug IMA402 targets tough cancers in early trial
Disease control Recruiting nowThe goal of this clinical trial is to evaluate the safety, tolerability and anti-tumor activity of IMA402 in patients with recurrent and/or refractory solid tumors. Primary objectives: * To determine the maximum tolerated doses and/or recommended doses for extensions for IMA402…
Phase 1/2 • Sponsor: Immatics Biotechnologies GmbH • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Laser zaps small breast tumors, no scalpel needed
Disease control Recruiting nowPrior to this confirmatory pivotal study, the multicenter Br-002 feasibility study was completed. 98% of tumors less than or equal to 15mm were completely ablated in one procedure.This study will evaluate Novilase for the focal destruction of malignant tumors of the breast that a…
Sponsor: Novian Health Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New oral drug shows promise for genetic high cholesterol
Disease control CompletedThe goal of this study is to evaluate the efficacy, safety, and tolerability of enlicitide decanoate in adult participants with heterozygous familial hypercholesterolemia. The primary hypothesis is that enlicitide decanoate is superior to placebo on mean percent change from basel…
Phase 3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Virtual reality plus exercise may sharpen aging brains
Disease control OngoingThe Interventions for Brain Health Virtual Reality Study is a NIH-funded clinical research trial at the University of California San Diego (UCSD) Health under the supervision of the study principal investigator Dr. Judy Pa. The overarching goal of this trial is to use a novel vir…
Sponsor: University of California, San Diego • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
New triple therapy aims to boost lung cancer survival
Disease control OngoingThis study is researching an investigational drug called fianlimab (also called REGN3767) with two other medications called cemiplimab and chemotherapy, individually called a "study drug" or collectively called "study drugs". 'Investigational' means that the study drug is not app…
Phase 2/3 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
New drug combo aims to outperform standard therapy for Hard-to-Treat blood cancers
Disease control Recruiting nowThe purpose of this study is to assess the safety and tolerability and to confirm the dose of nemtabrutinib in combination with venetoclax in participants with R/R CLL/SLL. The primary study hypotheses are that the combination of nemtabrutinib plus venetoclax is superior to VR wi…
Phase 3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
New drug BL-B01D1 targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThe objective of this study is to evaluate the safety, tolerability, and efficacy of BL-B01D1 in patients with Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors.
Phase 1 • Sponsor: SystImmune Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Less neck radiation may be just as effective for nasopharyngeal cancer
Disease control OngoingThis is a multi-center, non-inferiority, open-label, randomized controlled phase III clinical trial in primary diagnosed nasopharyngeal carcinoma (NPC) patients without distant metastasis. The purpose of this study is to evaluate the efficacy of reduced neck prophylactic radiothe…
Phase 3 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New targeted therapy shows promise for Tough-to-Treat lymphomas
Disease control Stopped earlyThis phase II trial tests whether loncastuximab tesirine works to shrink tumors in patients with B-cell malignancies that have come back (relapsed) or does not respond to treatment (refractory). Loncastuximab tesirine is a monoclonal antibody, called loncastuximab, linked to a ch…
Phase 2 • Sponsor: University of Washington • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Brain wave battle: deeper suppression may halt post-arrest seizures
Disease control Recruiting nowRESTORE is a randomized clinical trial investigating the safety and feasibility of using EEG treatment targets (burst suppression vs. seizure suppression) for post-cardiac arrest refractory status epilepticus treatment.
Phase 2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC